Cumberland Pharmaceuticals (CPIX) Current Assets (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Current Assets across 17 years of filings, most recently posting $32.8 million for Q1 2026.

• Current Assets for Q1 2026 came in at $32.8 million, up 2.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.8 million (up 2.86% YoY), and the FY2025 annual result was $37.1 million, up 1.67% from the prior year.
• Current Assets came in at $32.8 million for Q1 2026 at Cumberland Pharmaceuticals, down from $37.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $49.2 million in Q3 2022 to a low of $29.9 million in Q3 2025.
• The 5-year median for Current Assets is $36.5 million (2024), against an average of $38.6 million.
• Across the five-year window, Current Assets increased 4.12% in 2022 and decreased 22.14% in 2023, its largest moves.
• Cumberland Pharmaceuticals' Current Assets stood at $45.9 million in 2022, then fell by 22.14% to $35.7 million in 2023, then climbed by 2.07% to $36.5 million in 2024, then increased by 1.67% to $37.1 million in 2025, then fell by 11.52% to $32.8 million in 2026.
• The last three Current Assets figures came in at $32.8 million (Q1 2026), $37.1 million (Q4 2025), and $29.9 million (Q3 2025), per Business Quant data.